article thumbnail

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

Society of Thoracic Surgeons - Adult Cardiac

We wanted to examine our outcomes, and we were pleasantly surprised to find that the freedom from re-intervention was 91% at 10 years and 87% at 20 years. The CHSD is part of the STS National Database, one of the largest and most comprehensive clinical registries with nearly 10 million cardiothoracic procedures performed by 4,300+ surgeons.

article thumbnail

Staten Island University Hospital's Cardiothoracic Program Achieves Prestigious STS Three-Star Quality Ratings

DAIC

The cardiothoracic surgery programs at four Northwell Health hospitals received this distinguished accolade, showcasing their commitment to delivering exceptional care and achieving outstanding outcomes. This prestigious recognition places SIUH in the top echelons of surgical excellence.

article thumbnail

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Society of Thoracic Surgeons - Congenital

The study, leveraging data from the STS Adult Cardiac Surgery Database (ACSD), offers the most comprehensive analysis to date of prosthetic valve outcomes, encompassing over 100,000 patients. The study addressed a critical question in cardiac surgery: how age and valve type influence outcomes for patients undergoing surgical AVR.

article thumbnail

Surgeon Preference Impacts Survival Outcomes Analyses for CABG Patients

DAIC

Our analysis provides new insights on an important clinical questionwhether CABG with multiple arteries used as a conduit, rather than one artery and veins from the leg, may benefit patients by improving their long-term survival, said lead study author Justin Schaffer, MD, a cardiothoracic surgeon at Baylor Scott & White Health in Plano, Texas.

article thumbnail

TAVR System Shows Durable Clinical Outcomes, Strong Valve Performance in Low-Risk Aortic Stenosis Patients

DAIC

tim.hodson Mon, 03/31/2025 - 15:39 March 30, 2025 Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Allison Family Distinguished Chair of Cardiovascular Research and professor of cardiothoracic surgery at the Houston Methodist Hospital and principal investigator of the trial. Grubb, M.D.,

TAVR 52
article thumbnail

Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case

Frontiers in Cardiovascular Medicine

Recent advances in immunotherapy have significantly improved outcomes for cancer patients. However, therapies such as immune checkpoint inhibitors (ICIs) can lead to immune-related adverse events, including potentially fatal ICI-myocarditis.

article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. From a pool of 37,011 patients, the study identified 2,360 patients under the age of 60 years who underwent these procedures, with 22% receiving TAVR and 78% SAVR.